Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
Online ISSN : 1882-8272
Print ISSN : 0388-1601
ISSN-L : 0388-1601
Original Article
Studies on the Descriptions of Lab Test Considerations, Overdosage, Clinical Studies, and Miscellaneous Information in Precaution Section of Prescribing Information for Japanese Ethical Drugs
Akemi KAWAKAMI, Mariko IWASE, Hajime YASUHARA, Jun-Ichiro MURAYAMA
Author information
JOURNAL FREE ACCESS

2013 Volume 44 Issue 6 Pages 451-458

Details
Abstract
Purpose: To investigate better ways of providing information in package inserts for prescription drugs to make them easier for medical staff to use.
Methods: We investigated 100 randomly selected medicines, with or without high alert, to determine how frequently the four items: lab test considerations; overdosage; clinical studies; and miscellaneous information, are printed in the package inserts. We also sent a questionnaire to physicians and pharmacists at three hospitals in Showa University to investigate how these four items are being used.
Results: Documentation for lab test considerations, overdosage, clinical studies, and miscellaneous information, was included in 7%, 58%, 71%, and 92% of inserts, respectively. Response rate for physicians was 68% (198 of 290 questionnaires were returned) and 100% for pharmacists (107 of 107 questionnaires were returned). Collected data suggested that only half of physicians who participated in the study used the four insert items being investigated in this study. One reason given for items not being used was that the clinician had no opportunity for use. Forty-three percent of physicians and 69% of pharmacists reported that they were able to access the information they needed. It was also suggested that categories for which there was no information should be listed with contact details for alternative information sources.
Conclusion: The results above demonstrate that product information is useful and itemization of practical documentation would be helpful in providing medication to patients. Numbering of each item in package inserts is also helpful, and items for which there is no clinical information should also be included and the lack of information documented.
(Jpn J Clin Pharmacol Ther 2013; 44(6): 451-458)
Content from these authors
© 2013 The Japanese Society of Clinical Pharmacology and Therapeutics
Previous article Next article
feedback
Top